#GivingTuesday is a global day of giving fueled by the power of social media and collaboration.
CRI's Vanessa Lucey, Ph.D., discusses the immuno-onocology landscape in this webinar for the biotechnology industry.
CRI’s Vanessa Lucey will be a panelist during the "Landscape and Evolution of the Marketplace" talk at IO360 on February 27, 2020.
Free event for patients, caregivers, and advocates to learn about new breakthroughs in cancer immunotherapy in Seattle.
The Cancer Research Institute assembles a team to run and raise critical funds for highly promising cancer immunotherapy research.
Free event for patients, caregivers, and advocates to learn about new breakthroughs in cancer immunotherapy in Buffalo.
Vanessa M. Lucey, Ph.D., MBA, director of CRI Clinical Accelerator and Venture Fund, will also speak on a panel on May 6, 2020, at Convene in New York City.
2020 International Cancer Immunotherapy Conference takes place September 14-17, 2020, at the New York Hilton Midtown in New York City.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
Colorectal cancer veteran Gordon Levine discusses genomic testing, clinical trials, patient advocacy, and access to immunotherapy.
We spoke with Dr. Amanda Lund to learn more about her work and what she hopes to accomplish during the next five years as a CRI Lloyd J. Old STAR.